CANCER LETTERS 581 (2024) 216528 216555 MECHANISM OF RESISTANCE TO A PHASE-II IDELALISIB-BASED CLINICAL TRIAL IN CLL

被引：0
|
作者：
Mamidi, Murali K. [1 ]
Mahmud, Hasan [1 ]
Maiti, Guru P. [1 ]
Mendez, Mariana T. [2 ]
Fernandes, Stacey M. [3 ,4 ]
Vesely, Sara K. [1 ,5 ]
Holter-Chakrabarty, Jennifer [1 ]
Brown, Jennifer R. [3 ,4 ]
Ghosh, Asish K. [1 ,2 ]
机构：
[1] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Oklahoma City, OK USA
[2] Univ Oklahoma, Dept Pathol, Hlth Sci Ctr, Oklahoma City, OK USA
[3] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA USA
[4] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA
[5] Univ Oklahoma, Hudson Coll Publ Hlth, Hlth Sci Ctr, Oklahoma City, OK USA
来源：
CANCER LETTERS | 2024年 / 581卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IS27
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CANCER LETTERS 581 (2024) 216528 216538 METASTATIC HETEROGENEITY OF BREAST CANCER: A CONUNDRUM FOR CLINICAL TRANSLATION?
    Raman, Venu
    CANCER LETTERS, 2024, 581
  • [2] CANCER LETTERS 581 (2024) 216528 216533 THE APPLICATION OF AN EXTRACELLULAR VESICLE-BASED BIOSENSOR IN EARLY DIAGNOSIS AND PREDICTION OF CHEMORESPONSIVENESS IN OVARIAN CANCER
    Tsang, Benjamin K.
    Asare-Werehene, Meshach
    Hunter, Rob
    Gerber, Emma
    Reunov, Arkadiy
    Brine, Isaiah
    Chang, Chia-Yu
    Chang, Chia-Ching
    Shieh, Dar-Bin
    Burger, Dylan
    Anis, Hanan
    CANCER LETTERS, 2024, 581
  • [3] CANCER LETTERS 581 (2024) 216528 216531 DECIPHERING THE ADAPTIVE TRAMETINIB RESISTANCE IN LOW-GRADE OVARIAN SEROUS CARCINOMA AND ITS TRANSLATIONAL POTENTIAL
    Wong, Kwong-Kwok
    Ng, Chun-Wai
    Tsang, Yvonne
    Gershenson, David M.
    CANCER LETTERS, 2024, 581
  • [4] A PHASE-II CLINICAL-TRIAL OF CARBOPLATIN IN ADVANCED OVARIAN-CANCER
    POHL, J
    MEERPOHL, HG
    PFLEIDERER, A
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 61 - 61
  • [5] METASTATIC PROSTATE-CANCER - PHASE-II CLINICAL-TRIAL OF SPIROGERMANIUM
    BUI, NB
    CHAUVERGNE, J
    BRUNET, R
    RICHAUD, P
    HOERNI, B
    LAGARDE, C
    LEGUILLOU, M
    BULLETIN DU CANCER, 1986, 73 (01) : 65 - 67
  • [6] PHASE-II CLINICAL-TRIAL OF DOXIFLURIDINE IN PATIENTS WITH ADVANCED OVARIAN-CANCER
    VANOOSTEROM, AT
    HUININK, WWT
    VANDERBURG, MEL
    VERMORKEN, JB
    WILLEMSE, PHB
    NEIJT, JP
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (06) : 747 - 749
  • [7] PHASE-II CLINICAL-TRIAL OF CIS-DICHLORODIAMMINEPLATINUM IN GASTRIC-CANCER
    LACAVE, AJ
    IZARZUGAZA, I
    APARICIO, LMA
    PEREDA, MV
    MARCO, JMG
    BUESA, JM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (01): : 35 - 38
  • [8] A PHASE-II CLINICAL-TRIAL OF FLUTAMIDE IN THE TREATMENT OF ADVANCED BREAST-CANCER
    ZHAO, TP
    HE, GF
    TUMORI, 1988, 74 (01) : 53 - 56
  • [9] PHASE-II CLINICAL-TRIAL OF VP-16-213 IN OVARIAN-CANCER
    MASKENS, AP
    ARMAND, JP
    LACAVE, AJ
    DEJAGER, RL
    HANSEN, HH
    WOLFF, JPM
    CANCER TREATMENT REPORTS, 1981, 65 (3-4): : 329 - 330
  • [10] PHASE-II CLINICAL-TRIAL OF TRICYCLIC NUCLEOSIDE PHOSPHATE FOR ADVANCED COLORECTAL-CANCER
    OCONNELL, MJ
    RUBIN, J
    HAHN, RG
    KVOLS, LK
    MOERTEL, CG
    CANCER TREATMENT REPORTS, 1987, 71 (03): : 333 - 334
12345